Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moleculin Biotech (MBRX) Prepaid Assets (2016 - 2025)

Moleculin Biotech's Prepaid Assets history spans 10 years, with the latest figure at $808000.0 for Q4 2025.

  • Quarterly results put Prepaid Assets at $808000.0 for Q4 2025, down 11.79% from a year ago — trailing twelve months through Dec 2025 was $808000.0 (down 11.79% YoY), and the annual figure for FY2025 was $808000.0, down 11.79%.
  • Prepaid Assets for Q4 2025 was $808000.0 at Moleculin Biotech, up from $786000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $3.3 million in Q2 2022 to a low of $293000.0 in Q1 2025.
  • The 5-year median for Prepaid Assets is $1.8 million (2021), against an average of $1.7 million.
  • The sharpest move saw Prepaid Assets surged 636.19% in 2021, then crashed 86.26% in 2025.
  • Year by year, Prepaid Assets stood at $589000.0 in 2021, then surged by 316.13% to $2.5 million in 2022, then tumbled by 76.99% to $564000.0 in 2023, then surged by 62.41% to $916000.0 in 2024, then decreased by 11.79% to $808000.0 in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $808000.0, $786000.0, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.